Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other financing activities (2021 - 2022)

Historic Other financing activities for HeartSciences (HSCS) over the last 2 years, with Q2 2022 value amounting to $7625.0.

  • HeartSciences' Other financing activities fell 9998.4% to $7625.0 in Q2 2022 from the same period last year, while for Apr 2021 it was $47.7 million, marking a year-over-year change of. This contributed to the annual value of $48.3 million for FY2022, which is 143.1% up from last year.
  • Per HeartSciences' latest filing, its Other financing activities stood at $7625.0 for Q2 2022, which was down 9998.4% from $370894.0 recorded in Q1 2022.
  • In the past 5 years, HeartSciences' Other financing activities registered a high of $47.7 million during Q2 2021, and its lowest value of $7625.0 during Q2 2022.